Tirzepatide

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Research indicates roles in glycaemic control, weight management, metabolic syndrome and insulin sensitisation. >99% purity by HPLC. Lyophilised powder in a sealed vial.

40mg Vial / Pen >99% Purity HPLC Verified

Format

Vial £115 / 40mg

Pen £125 / 40mg

Quantity

For in-vitro research use only. Not for human or veterinary use.

Specifications

Compound	Tirzepatide
Molecular Weight	4813.45 g/mol
Purity	>99% (HPLC)
Form	Lyophilised powder
Quantity	40mg / vial
Storage	<−20°C, protect from light